| INSM1 expression in primary and metastatic neuroendocrine neoplasms at distinct locations. | INSM1 expression in primary and metastatic neuroendocrine neoplasms at distinct locations.
Wang XQ, Fu J, Zhang YT, Xu Y. | 01/29/2024 |
| Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions. | Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
Lenz J, Klubíčková N, Ptáková N, Hájková V, Grossmann P, Šteiner P, Kinkor Z, Švajdler M, Michal M, Konečná P, Macháčová D, Hurník P, Tichý M, Tichý F, Kyllar M, Fiala L, Kavka M, Michal M. | 04/4/2023 |
| Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix. | Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix.
Kuji S, Endo A, Kubota M, Uekawa A, Kawakami F, Mikami Y, Koike J, Suzuki N., Free PMC Article | 01/11/2023 |
| Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma. | Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma.
Kashima J, Hashimoto T, Yoshida A, Goto Y, Ushiku T, Ohe Y, Watanabe SI, Yatabe Y. | 12/24/2022 |
| INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance. | INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance.
Zhang Q, Dong Y, Zhou M, Guo Y, Lou L, Qu Z, Zheng Y, Duan Y., Free PMC Article | 12/24/2022 |
| Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin. | Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.
Mathew JG, Bowman AS, Saab J, Busam KJ, Nehal K, Pulitzer M., Free PMC Article | 05/14/2022 |
| Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation. | Exploration of INSM1 and hASH1 as additional markers in lung cytology samples of high-grade neuroendocrine carcinoma with indeterminate neuroendocrine differentiation.
Rothrock AT, Stewart J 3rd, Li F, Racila E, Amin K. | 04/9/2022 |
| Utility of Insulinoma-Associated Protein 1 (INSM1) and Mucin 2 (MUC2) Immunohistochemistry in the Distinction of Endocrine Mucin-Producing Sweat Gland Carcinoma From Morphologic Mimics. | Utility of Insulinoma-Associated Protein 1 (INSM1) and Mucin 2 (MUC2) Immunohistochemistry in the Distinction of Endocrine Mucin-Producing Sweat Gland Carcinoma From Morphologic Mimics.
Quattrochi B, Russell-Goldman E. | 03/26/2022 |
| INSM1 Expression in Breast Neoplasms with Neuroedocrine Features. | INSM1 Expression in Breast Neoplasms with Neuroedocrine Features.
Metovic J, Castellano I, Marinelli E, Osella-Abate S, Sapino A, Cassoni P, Papotti M., Free PMC Article | 03/26/2022 |
| Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features. | Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
Turkevi-Nagy S, Báthori Á, Böcz J, Krenács L, Cserni G, Kővári B., Free PMC Article | 02/12/2022 |
| Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization. | Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.
Capodanno Y, Chen Y, Schrader J, Tomosugi M, Sumi S, Yokoyama A, Hiraoka N, Ohki R., Free PMC Article | 02/5/2022 |
| Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma. | Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
Seok JY, Kang M, De Peralta-Venturina M, Fan X. | 01/8/2022 |
| Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast. | Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
Seijnhaeve E, Galant C, Van Bockstal MR. | 12/18/2021 |
| A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm. | A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
Guo W, Farzaneh T, Lee W, Nael A, Li X, Chandan VS. | 12/11/2021 |
| A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma. | A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
Chen C, Lan MS., Free PMC Article | 12/4/2021 |
| Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information? | Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
Machado I, Navarro S, López-Guerrero JA, Verdini L, Picci P, Giner F, Llombart-Bosch A. | 11/6/2021 |
| [Expression of CD200 and INSM1 in gastrointestinal and pancreatic neuroendocrine neoplasms and its diagnostic values]. | [Expression of CD200 and INSM1 in gastrointestinal and pancreatic neuroendocrine neoplasms and its diagnostic values].
Cao Z, Cen HB, Wei JG, Qin LZ, Liao W, Ao QL. | 10/16/2021 |
| INSM1 Expression in Chordomas. | INSM1 Expression in Chordomas.
Dridi M, Boutonnat J, Dumollard JM, Peoc'h M, Karpathiou G. | 09/25/2021 |
| Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective. | Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.
Kawasaki T, Kaira K. | 08/7/2021 |
| Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases. | Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases.
Sappenfield R, Gonzalez IA, Cao D, Chatterjee D. | 04/3/2021 |
| Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56. | Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
Chen JF, Yang C, Sun Y, Cao D. | 04/3/2021 |
| Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears. | Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
Hou T, Gan Q, Joseph CT, Sun X, Gong Y. | 02/27/2021 |
| Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56. | Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R, Kitazono S, Yanagitani N, Horiike A, Ichinose J, Matsuura Y, Nakao M, Mun M, Nishio M, Okumura S, Motoi N, Ito T, Miyazaki Y, Inase N, Ishikawa Y. | 10/24/2020 |
| Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors. | Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D, Viswanathan K, Goyal A, Rao R. | 08/29/2020 |
| Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery. | Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery.
Song R, Wei X, Wang Y, Hu S, Ba Y, Xiao X, Zhang J. | 08/22/2020 |